DocSym
β
Searchsearch
Search
(M33.9) Dermatopolymyositis, unspecified
More details coming soon
315 251 in individuals diagnosis dermatopolymyositis, unspecified confirmed
7 402 deaths with diagnosis dermatopolymyositis, unspecified
2% mortality rate associated with the disease dermatopolymyositis, unspecified
Diagnosis dermatopolymyositis, unspecified is diagnosed Women are 30.92% more likely than Men
108 884
Men receive the diagnosis dermatopolymyositis, unspecified
3 122 (2.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
206 367
Women receive the diagnosis dermatopolymyositis, unspecified
4 280 (2.1 %)Died from this diagnosis.
Risk Group for the Disease dermatopolymyositis, unspecified - Men and Women aged 55-59
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 0-1, 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features dermatopolymyositis, unspecified
Absence or low individual and public risk
Dermatopolymyositis, unspecified - what does this mean
Dermatopolymyositis is a rare autoimmune disorder that causes inflammation of the muscles and skin. it is characterized by muscle weakness, skin rash, and inflammation of the blood vessels and muscles. it is caused by the body's immune system attacking its own tissues, leading to inflammation.
What happens during the disease - dermatopolymyositis, unspecified
Dermatopolymyositis is an inflammatory disorder of the skin and muscles that is thought to have an autoimmune etiology. it is believed that the immune system mistakenly attacks healthy muscle and skin cells, leading to inflammation and tissue damage. this inflammation can lead to muscle weakness, skin rashes, and other symptoms.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination and medical history
- Blood tests to measure levels of muscle enzymes, such as creatine kinase
- Muscle biopsy to confirm diagnosis
- Imaging tests such as MRI or CT scan to assess muscle and soft tissue damage
- Electromyography (EMG) to measure electrical activity in the muscles
- Nerve conduction studies to measure electrical activity in the nerves
- Skin biopsy to evaluate skin changes
Treatment and Medical Assistance
Main goal of the treatment: To reduce inflammation, improve muscle strength, and improve quality of life.
- Prescribing corticosteroids and other immunosuppressants to reduce inflammation
- Physical and occupational therapy to improve muscle strength and function
- Administering intravenous immunoglobulin (IVIG) to suppress the immune system
- Prescribing medications to reduce pain
- Administering plasma exchange to remove antibodies
- Providing psychological support to help manage stress and depression
- Recommending lifestyle changes to improve overall health and quality of life
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Dermatopolymyositis, unspecified - Prevention
The best way to prevent dermatopolymyositis, unspecified is to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management. additionally, it is important to protect skin from sun exposure by using sunscreen and wearing protective clothing when outdoors. finally, avoiding contact with any known irritants or allergens can help reduce the risk of developing the disease.